Cutaneous leishmaniasis in a patient with psoriatic arthritis treated with tumour necrosis factor-α inhibitor

NV Morsing1 Department of Internal Medicine, Regional Hospital Gødstrup, Herning, Denmark

https://orcid.org/0009-0005-8070-3834

CM Andreasen1 Department of Internal Medicine, Regional Hospital Gødstrup, Herning, Denmark

https://orcid.org/0000-0002-2376-0446

TA Rasmussen2 Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark

https://orcid.org/0000-0001-5354-2442

LT Moll1 Department of Internal Medicine, Regional Hospital Gødstrup, Herning, DenmarkCorrespondence[email protected]

https://orcid.org/0000-0003-4132-0310

"Cutaneous leishmaniasis in a patient with psoriatic arthritis treated with tumour necrosis factor-α inhibitor." Scandinavian Journal of Rheumatology, 53(2), pp. 158–159

Disclosure statement

No potential conflict of interest was reported by the authors.

Informed consent

The patient has read and consented to the publication of this case report.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Cutaneous leishmaniasis in a patient with psoriatic arthritis treated with tumour necrosis factor-α inhibitor

Information for

Open access

Opportunities

Help and information

Cutaneous leishmaniasis in a patient with psoriatic arthritis treated with tumour necrosis factor-α inhibitor

Disclosure statement

Informed consent

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature